---
title: "Kuehn Law Encourages Investors of Syndax Pharmaceuticals, Inc. to Contact Law Firm"
date: "2025-02-11 06:50:55"
summary: "NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms...."
categories:
  - "morningstar"
lang:
  - "en"
translations:
  - "en"
tags:
  - "morningstar"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of **Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX)** breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.

If you are **a long-term** **SNDX stockholder** please contact [Justin Kuehn, Esq. here](https://www.globenewswire.com/Tracker?data=ssQ7k1UpiG4uYc6l_XdJrWbRsacp8izKV8usoFus4MOo6xdcvW1f3OePNyAZXHXuoFTJGBA9X289S6n29Idb2z3d3QrjRf5g-lQ1khraY04EuhqfNo1VhMqG_aHMgCszvSzP_ATU_NOA1by4xrvSYQ==), by email at [justin@kuehn.law](https://www.globenewswire.com/Tracker?data=yQanfH16axJHtNuun4gku50iYze1RRnqb8VrNIWaJSb2K0jQ65r7A4VbHAl9g9Vsu54km--cVcpkUZtAv6rdgQ==), or call (833) 672-0814. **The consultation and case are free with no obligation to you. Kuehn Law pays all case costs and does not charge its investor clients.** *Shareholders should contact the firm immediately as there may be limited time to enforce your rights.*

**Why Your Participation Matters:**

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. *Your investment. Your voice. Your future.*™

For additional information, please visit [Shareholder Derivative Litigation – Kuehn Law](https://www.globenewswire.com/Tracker?data=xH9EhHns6BuR15DhO-QbaV6kAIet_zDgoHBJMXKZU8MqhefIdVDsFU9P3cddWLA2iU373P_nSZvWkkWxOhkwtgOcC2CbuRISIFsFUy5RLFJYDFDojQUW5r104z2c1I9bBmk2JBaJi9AQ6LHlRd2bMJarwOeNfblfV3_vuP44-WYdcPIDLDzsZTtiuOvQb3Cg).

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:  
Kuehn Law, PLLC  
Justin Kuehn, Esq.  
53 Hill Street, Suite 605   
Southampton, NY 11968  
[justin@kuehn.law](https://www.globenewswire.com/Tracker?data=yQanfH16axJHtNuun4gku6VpQnmw0F0Vv8ugsP7T9eXHIZWmMEWaFvREJLyjV3tsEmDStFqy6K8KoNvPvoMC-g==)  
(833) 672-0814

 ![](https://www.globenewswire.com/newsroom/ti?nf=OTM1NjA3NyM2NzQ0NTAzIzIyODUyNTU=)   
 ![](https://ml.globenewswire.com/media/YjVkY2FlYWQtNjEyZC00M2IzLWFjMTAtMzc4MDkzZmFhNGYyLTEyOTY4MDU=/tiny/KUEHN-LAW-PLLC.png)

 [![](https://ml.globenewswire.com/media/83bde11e-8ae3-488a-a2c9-2ce956c44090/small/klaw-png.png)](https://www.globenewswire.com/NewsRoom/AttachmentNg/83bde11e-8ae3-488a-a2c9-2ce956c44090)

[morningstar](https://www.morningstar.com/news/globe-newswire/9356077/kuehn-law-encourages-investors-of-syndax-pharmaceuticals-inc-to-contact-law-firm)
